Copeland Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-38
| Closed | -$2.21K | – | 280 |
|
|
2023
Q3 | $2.21K | Hold |
38
| – | – | ﹤0.01% | 275 |
|
|
2023
Q2 | $2.43K | Hold |
38
| – | – | ﹤0.01% | 292 |
|
|
2023
Q1 | $3K | Hold |
38
| – | – | ﹤0.01% | 236 |
|
|
2022
Q4 | $3K | Hold |
38
| – | – | ﹤0.01% | 239 |
|
|
2022
Q3 | $3K | Hold |
38
| – | – | ﹤0.01% | 225 |
|
|
2022
Q2 | $3K | Hold |
38
| – | – | ﹤0.01% | 228 |
|
|
2022
Q1 | $3K | Hold |
38
| – | – | ﹤0.01% | 238 |
|
|
2021
Q4 | $2K | Hold |
38
| – | – | ﹤0.01% | 268 |
|
|
2021
Q3 | $2K | Hold |
38
| – | – | ﹤0.01% | 265 |
|
|
2021
Q2 | $3K | Hold |
38
| – | – | ﹤0.01% | 229 |
|
|
2021
Q1 | $2K | Hold |
38
| – | – | ﹤0.01% | 262 |
|
|
2020
Q4 | $2K | Hold |
38
| – | – | ﹤0.01% | 254 |
|
|
2020
Q3 | $2K | Hold |
38
| – | – | ﹤0.01% | 227 |
|
|
2020
Q2 | $2K | Hold |
38
| – | – | ﹤0.01% | 213 |
|
|
2020
Q1 | $2K | Buy |
+38
| New | +$2K | ﹤0.01% | 209 |
|